Search Results

Targeted combination therapies for leukemia with NUP98 translocations

Leukemia patients with chromosomal translocations of the Nucleoporin (NUP98) gene suffer from very poor prognosis. In this project we will identify ne…

FDA Approves New Formulation of Important Childhood Leukemia Drug

The U.S. Food and Drug Administration yesterday approved nelarabine injection, a critical treatment for acute lymphoblastic leukemia (), an aggressiv…

Lower Dose Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia

regimens are the standard of care for many patients with acute myeloid leukemia (AML) and are highly active therapeutic strategies for this challengin…

The Leukemia & Lymphoma Society Expands Information Resource Center Hours

For Immediate ReleaseContact: Andrea GreifTel: () -8958Cell: () [email protected] ReleaseThe Leukemia & Lymphoma Society Expands Informati…

2012 Leukemia Ball Toasts 25 Years of Making a Difference

Leukemia Ball Toasts Years of Making a Difference Silver Anniversary Gala to Feature Performances by Classic Rock Band Foreigner and …

Leukemia & Lymphoma Society Board of Trustees, Southern Florida Chapter

Carolyn Cauceglia—Chair VP, Amadeus North America Inc. Vicky Garcia—Vice Chair COO & , Cruise Planners Michael Romagnolo—Vice Chair SVP, Sent…

Chronic myeloid leukemia (CML) in children and young adults

Most cases of CML occur in adults. From -, less than percent of all cases of CML occurred in children, adolescents, and young adults younger than .

Treating Acute Leukemias: Blood Cancer United-NMDP Project ECHO Series

Leukemia Patient’s Legacy Helps Drive Innovative Cancer Clinical Trial

Rye Brook, NY (March , ) - Turning sorrow into action, The Harry T. Mangurian Jr. Foundation, whose namesake died from acute myeloid leukemia (AML), c…

LLS National Research Registry Progress Report - Chronic Lymphocytic Leukemia

LLS would like to thank all of the Chronic Lymphocytic Leukemia patients who contributed to the National Research Registry. Please see the report belo…

NRG Announces New Partnership with The Leukemia & Lymphoma Society

Los Angeles, CA - (September , ) - NRG announced The Leukemia & Lymphoma Society (LLS), the global leader in the fight to end blood cancer, as the tea…

Burlington and The Leukemia and Lymphoma Surprise a Young Survivor

Chronic Lymphocytic Leukemia (CLL): What Are My Treatment Options?

Please join The Leukemia & Lymphoma Society for a webcast for patients and caregivers. We invite you to learn more about: -Treatment options for CLL…

Chronic Lymphocytic Leukemia (CLL): What Are My Treatment Options?

Topics Covered We invite you to learn more about: Treatment options for CLL management Ways to effectively communicate with your healthcare tea…

Acute Myeloid Leukemia: Diagnosis, Treatment and Side Effect Management

Click Here to ParticipateRecorded on: February , 2025Estimated Time to Complete: . hours1. CE Credits/Contact hours for nurses and social workers avai…

FDA Approves a Patient-Friendly, Dissolvable Therapeutic for Chronic Myeloid Leukemia

The dissolvable format may also benefit individuals who have difficulty swallowing pills, offering greater flexibility and ease of use.

The Leukemia & Lymphoma Society and Blood Cancer UK Team Up to Award $4.25M for Research into Ways to Prevent Leukemia

RYE BROOK, N.Y., February , — The Leukemia & Lymphoma Society (LLS) and Blood Cancer UK announced today a , $. million grant to launch a research pro…

Leukemia Research Foundation of Delaware Commits $1 million to The Dare to Dream Project

The Leukemia Research Foundation of Delaware (LRFDE), founded by Denni Ferrara, has committed $ million to support pediatric leukemia research through…

Neonatal origins of pediatric AML

Children get different types of leukemias than adults. Even if the leukemias look the same under the microscope, the mutations are different. We are t…

Epigenetic heterogeneity in age-related clonal hematopoiesis and acute myeloid leukemia

Our focus is to unravel how clonal hematopoiesis (CH) progresses to leukemia. We will investigate how epigenetic heterogeneity affects Tet2-mutant hem…

Cotargeting oncogenic protein translation and apoptosis in acute myeloid leukemia

The focus of my research is to evaluate the efficacy of and to unravel the molecular mechanisms underpinning a novel drug combination in AML targeting…

Targeting Leukemia Stem Cells with the Novel Antibody Drug Conjugate

To improve the cure rate of patients suffering from acute myeloid leukemia (AML), our study aims to target resistant leukemia stem cells by developing…

Leveraging p53 to Improve Menin Inhibition in Leukemia Therapy

Acute myeloid leukemia remains a highly lethal disease. Menin inhibitors are an exciting new class of drugs in leukemic but are rarely curative and ha…

Student Trailblazers, Part 2: leukemia survivor studies cancer’s impact on caregivers

- studies cancer's effects on caregivers

FDA Approves New Treatment for Adults with Chronic Myeloid Leukemia

Asciminib provides another option to help CML patients live longer, healthier lives RYE BROOK, N.Y., December , – The U.S. Food and Drug Administrati…